Agasti 2021: I-Food and Drug Administration igunyaze i-asparaginase erwinia chrysanthemi (i-recombinant)-rywn) (i-Rylaze, i-Jazz Pharmaceuticals, Inc.) njengengxenye yohlobo lwemithi ye-chemotherapeutic enama-agent amaningi yokwelashwa kwe-acute lym.